This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by CONNER, J. T. Articles by KATZ, R. L. Search for Related Content PubMed PubMed Citation Articles by CONNER, J. T. Articles by KATZ, R. L.

Morphine and Promethazine as Intravenous Premedicants

JAMES T. CONNER, MD^*, J. WELDON BELLVILLE, MD, RONALD WENDER, MD, SUSAN WAPNER, RN, FREDERICK J. DOREY, PhD^||, and RONALD L. KATZ, MD^**

*Assistant Professor, Anesthesiology. Professor, Anesthesiology. Resident, Anesthesiology. Research Nurse. ||Statistician, Department of Biomathematics. **Professor and Chairman, Department of Anesthesiology. Department of Anesthesiology, UCLA School of Medicine, Los Angeles, California 90024.

Abstract

Los Angeles, Californiatt Two hundred seventy patients received morphine 5 mg or 10 mg alone or with promethazine 6.25 mg, 12.5 mg, or 25 mg. Promethazine 25 mg alone also was studied. All drugs were given intravenously. Anxiety relief, sedation, patient acceptance, lack of recall, and side effects were the variables examined. Promethazine improved relief of anxiety, sedation, and patient acceptance when added to morphine. Doses of promethazine larger than 12.5 mg intravenously failed to improve these effects. Memory remained unaffected by any of the drugs.

Key Words: PREMEDICATION • ANALGESICS, morphine • ATARACTICS, promethazine